Clinical Trials
3
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Study in Adults to Assess the Safety and Efficacy of Inhaled IBIO123, for Post-exposure Prophylaxis of COVID-19
- Conditions
- COVID-19
- First Posted Date
- 2022-12-06
- Last Posted Date
- 2023-05-22
- Lead Sponsor
- Immune Biosolutions Inc
- Target Recruit Count
- 200
- Registration Number
- NCT05639166
- Locations
- 🇿🇦
Jongaie Research, Pretoria West, Pretoria, South Africa
🇺🇦Central City Clinical Hospital of Chernivtsi City Council, Chernivtsi, Chernivetska, Ukraine
🇺🇦City Clinical Hospital #1 of Ivano-Frankivsk City Council, Ivano-Frankivs'k, Ivano-Frankivsk Oblast, Ukraine
Phase 1&2 Study to Evaluate the Safety & Efficacy of Inhaled IBIO123 in Severe COVID-19 Illness
- Conditions
- COVID-19
- First Posted Date
- 2022-03-31
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- Immune Biosolutions Inc
- Target Recruit Count
- 123
- Registration Number
- NCT05303376
- Locations
- 🇿🇦
JOHESE UNITAS Hospital, Lyttelton, Centurion, South Africa
🇿🇦JOHESE ZAH Hospital, Pretoria, Gauteng, South Africa
🇺🇦Central City Clinical Hospital of Ivano-Frankivsk City Council, Ivano-Frankivs'k, Ivano-Frankivsk Oblast, Ukraine
Phase 1/2 Study to Evaluate the Efficacy and Safety of Inhaled IBIO123 in Participants With Mild to Moderate COVID-19 Illness
- Conditions
- COVID-19
- First Posted Date
- 2022-03-28
- Last Posted Date
- 2023-05-01
- Lead Sponsor
- Immune Biosolutions Inc
- Target Recruit Count
- 162
- Registration Number
- NCT05298813
- Locations
- 🇧🇷
Santa Casa de Misercórdia de Passos, Passos, Minas Gerais, Brazil
🇧🇷Instituto Brasil de Pesquisa Clinica, Gloria, Rio De Janeiro, Brazil
🇧🇷Clinica Supera Oncologia, Chapecó, Santa Catarina, Brazil